Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Doxorubicin loading fucoidan acetate nanoparticles for immune and chemotherapy in cancer treatment.

Lee KW, Jeong D, Na K.

Carbohydr Polym. 2013 May 15;94(2):850-6. doi: 10.1016/j.carbpol.2013.02.018.

PMID:
23544642
2.

Redox-responsive nanoparticles from the single disulfide bond-bridged block copolymer as drug carriers for overcoming multidrug resistance in cancer cells.

Wang YC, Wang F, Sun TM, Wang J.

Bioconjug Chem. 2011 Oct 19;22(10):1939-45. doi: 10.1021/bc200139n.

PMID:
21866903
3.

A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells.

Wong HL, Rauth AM, Bendayan R, Manias JL, Ramaswamy M, Liu Z, Erhan SZ, Wu XY.

Pharm Res. 2006 Jul;23(7):1574-85.

PMID:
16786442
4.

Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance.

Zeng X, Morgenstern R, Nyström AM.

Biomaterials. 2014 Jan;35(4):1227-39. doi: 10.1016/j.biomaterials.2013.10.042.

5.

Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism.

Shen J, He Q, Gao Y, Shi J, Li Y.

Nanoscale. 2011 Oct 5;3(10):4314-22. doi: 10.1039/c1nr10580a.

PMID:
21892492
6.

One-pot synthesis of sustained-released doxorubicin silica nanoparticles for aptamer targeted delivery to tumor cells.

He X, Hai L, Su J, Wang K, Wu X.

Nanoscale. 2011 Jul;3(7):2936-42. doi: 10.1039/c0nr00913j.

PMID:
21623439
7.

pH-Dependent doxorubicin release from terpolymer of starch, polymethacrylic acid and polysorbate 80 nanoparticles for overcoming multi-drug resistance in human breast cancer cells.

Shalviri A, Raval G, Prasad P, Chan C, Liu Q, Heerklotz H, Rauth AM, Wu XY.

Eur J Pharm Biopharm. 2012 Nov;82(3):587-97. doi: 10.1016/j.ejpb.2012.09.001.

PMID:
22995704
8.

The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles.

Min KH, Lee HJ, Kim K, Kwon IC, Jeong SY, Lee SC.

Biomaterials. 2012 Aug;33(23):5788-97. doi: 10.1016/j.biomaterials.2012.04.057.

PMID:
22591612
9.

Enhanced doxorubicin delivery and cytotoxicity in multidrug resistant cancer cells using multifunctional magnetic nanoparticles.

Pilapong C, Keereeta Y, Munkhetkorn S, Thongtem S, Thongtem T.

Colloids Surf B Biointerfaces. 2014 Jan 1;113:249-53. doi: 10.1016/j.colsurfb.2013.09.005.

PMID:
24103503
10.

Doxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapy.

Kang KW, Chun MK, Kim O, Subedi RK, Ahn SG, Yoon JH, Choi HK.

Nanomedicine. 2010 Apr;6(2):210-3. doi: 10.1016/j.nano.2009.12.006.

PMID:
20060074
11.

Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.

Jain A, Agarwal A, Majumder S, Lariya N, Khaya A, Agrawal H, Majumdar S, Agrawal GP.

J Control Release. 2010 Dec 20;148(3):359-67. doi: 10.1016/j.jconrel.2010.09.003.

PMID:
20854859
12.

Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.

Fan L, Li F, Zhang H, Wang Y, Cheng C, Li X, Gu CH, Yang Q, Wu H, Zhang S.

Biomaterials. 2010 Jul;31(21):5634-42. doi: 10.1016/j.biomaterials.2010.03.066.

PMID:
20430433
13.

Chitosan oligosaccharide-arachidic acid-based nanoparticles for anti-cancer drug delivery.

Termsarasab U, Cho HJ, Kim DH, Chong S, Chung SJ, Shim CK, Moon HT, Kim DD.

Int J Pharm. 2013 Jan 30;441(1-2):373-80. doi: 10.1016/j.ijpharm.2012.11.018.

PMID:
23174411
14.

In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.

Wong HL, Rauth AM, Bendayan R, Wu XY.

Eur J Pharm Biopharm. 2007 Mar;65(3):300-8.

PMID:
17156986
15.

Overcoming multidrug resistance of breast cancer cells by the micellar doxorubicin nanoparticles of mPEG-PCL-graft-cellulose.

Chen CH, Cuong NV, Chen YT, So RC, Liau I, Hsieh MF.

J Nanosci Nanotechnol. 2011 Jan;11(1):53-60.

PMID:
21446406
16.

Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance.

Wang J, Sun J, Chen Q, Gao Y, Li L, Li H, Leng D, Wang Y, Sun Y, Jing Y, Wang S, He Z.

Biomaterials. 2012 Oct;33(28):6877-88. doi: 10.1016/j.biomaterials.2012.06.019.

PMID:
22770799
17.

Nanoparticle carriers based on copolymers of poly(ε-caprolactone) and hyperbranched polymers for drug delivery.

Wang T, Li M, Gao H, Wu Y.

J Colloid Interface Sci. 2011 Jan 1;353(1):107-15. doi: 10.1016/j.jcis.2010.09.053.

PMID:
20947092
18.

Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles.

Lee AL, Dhillon SH, Wang Y, Pervaiz S, Fan W, Yang YY.

Mol Biosyst. 2011 May;7(5):1512-22. doi: 10.1039/c0mb00266f.

PMID:
21350763
19.

Enhanced chemotherapy of cancer using pH-sensitive mesoporous silica nanoparticles to antagonize P-glycoprotein-mediated drug resistance.

Huang IP, Sun SP, Cheng SH, Lee CH, Wu CY, Yang CS, Lo LW, Lai YK.

Mol Cancer Ther. 2011 May;10(5):761-9. doi: 10.1158/1535-7163.MCT-10-0884.

20.

[The in vitro cytotoxicity and in vivo toxicity of doxorubicin antiresistant stealth liposomes].

Wang JC, Liu XY, Lü WL, Lee HS, Goh BC, Zhang Q.

Yao Xue Xue Bao. 2005 May;40(5):475-80. Chinese.

PMID:
16220797
Items per page

Supplemental Content

Support Center